Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice

Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice

Fibroblast growth factor 21 (FGF21) is a promising therapeutic agent for treatment of type 2 diabetes (T2D) and non-alcoholic steatohepatitis (NASH). We show that therapeutic levels of FGF21 were achieved following subcutaneous (s.c.) administration of mRNA encoding human FGF21 proteins. The efficac...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefano Bartesaghi (Author), Kristina Wallenius (Author), Daniel Hovdal (Author), Mathias Liljeblad (Author), Simonetta Wallin (Author), Niek Dekker (Author), Louise Barlind (Author), Nigel Davies (Author), Frank Seeliger (Author), Maria Sörhede Winzell (Author), Sima Patel (Author), Matt Theisen (Author), Luis Brito (Author), Nils Bergenhem (Author), Shalini Andersson (Author), Xiao-Rong Peng (Author)
Format: Book
Published: Elsevier, 2022-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items